Is NRBO or EQR a better dividend investment in 2026?

NRBO currently yields 84.75% with a 5% 5-year dividend growth rate. EQR yields 5.87% with 5% growth. The better choice depends on your goal: NRBO offers higher current income.

What is the dividend yield difference between NRBO and EQR?

NRBO has a forward dividend yield of 84.75% ($2.00/share annually). EQR yields 5.87% ($3.47/share annually). The yield gap is 78.88 percentage points.

Home › Compare › NRBO vs EQR

NRBO vs EQR: Dividend Comparison 2026

NRBO yields 84.75% · EQR yields 5.87%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 NRBO wins by $2.00M in total portfolio value

INVESTMENT

TIME HORIZON10 years

NRBO

● Live price

84.75%

Share price

$2.36

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$2.05M

Annual income

$615,863.14

Full NRBO calculator →

EQR

● Live price

5.87%

Share price

$59.15

Annual div

$3.47

5Y div CAGR

15.8%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$47.8K

Annual income

$5,475.61

Full EQR calculator →

Portfolio growth — NRBO vs EQR

📍 NRBO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	NRBO	EQR
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, NRBO + EQR cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

NRBO pays

EQR pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NRBO

Annual income on $10K today (after 15% tax)

$7,203.39/yr

After 10yr DRIP, annual income (after tax)

$523,483.67/yr

EQR

Annual income on $10K today (after 15% tax)

$499.01/yr

After 10yr DRIP, annual income (after tax)

$4,654.27/yr

At 15% tax rate, NRBO beats the other by $518,829.40/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NRBO + EQR for your $10,000?

NRBO: 50%EQR: 50%

100% EQR50/50100% NRBO

Portfolio after 10yr

$1.05M

Annual income

$310,669.37/yr

Blended yield

29.68%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

NRBO

Analyst Ratings

Buy

Consensus: Buy

Altman Z

-20.1

Piotroski

0/9

EQR

Analyst Ratings

Buy

Hold

Sell

Consensus: Hold

Price Target

$70.35

+18.9% upside vs current

Range: $63.00 — $78.50

Altman Z

1.8

Piotroski

7/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NRBO buys

EQR buys

No recent congressional trades found for NRBO or EQR in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricNRBOEQR

Forward yield	84.75% ✓	5.87%
Annual dividend / share	$2.00	$3.47 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	15.8% ✓
Portfolio after 10y	$2.05M	$47.8K ✓
Annual income after 10y	$615,863.14 ✓	$5,475.61
Total dividends collected	$1.79M	$23.0K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	REIT
Analyst consensus	Buy	Hold

Year-by-year: NRBO vs EQR ($10,000, DRIP)

Year	NRBO Portfolio	NRBO Income/yr	EQR Portfolio	EQR Income/yr	Gap
1← crossover	$19,175	$8,474.58	$11,380	$679.82	+$7.8K → NRBO
2	$35,703	$15,186.58	$13,014	$837.25	+$22.7K → NRBO
3	$64,630	$26,427.72	$14,961	$1,036.20	+$49.7K → NRBO
4	$113,864	$44,709.84	$17,297	$1,289.22	+$96.6K → NRBO
5	$195,450	$73,615.70	$20,121	$1,613.15	+$175.3K → NRBO
6	$327,228	$118,096.19	$23,561	$2,030.84	+$303.7K → NRBO
7	$534,919	$184,784.73	$27,783	$2,573.54	+$507.1K → NRBO
8	$854,669	$282,305.61	$33,013	$3,284.39	+$821.7K → NRBO
9	$1,336,042	$421,546.65	$39,547	$4,223.51	+$1.30M → NRBO
10	$2,045,428	$615,863.14	$47,791	$5,475.61	+$2.00M → NRBO

NRBO vs EQR: Complete Analysis 2026

NRBO — Stock

NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for neurodegenerative, infectious, and cardiometabolic diseases. Its therapeutics programs include ANA001, an oral niclosamide formulation, which is in Phase 2/3 clinical trials to treat patients with moderate coronavirus disease (COVID-19); NB-01 for the treatment of painful diabetic neuropathy; NB-02 to treat the symptoms of cognitive impairment and modify the progression of neurodegenerative diseases associated with the malfunction of tau protein; and Gemcabene, an acute indication for COVID-19. NeuroBo Pharmaceuticals, Inc. is headquartered in Boston, Massachusetts.

Full NRBO Calculator →

EQR — REIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →

📬

Get this NRBO vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NRBO vs SCHD NRBO vs JEPI NRBO vs O NRBO vs KO NRBO vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.